Stock LIPUM LIPUM AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Lipum AB

Equities

LIPUM

SE0015660899

Market Closed - Nasdaq Stockholm
Other stock markets
 10:51:45 2024-05-03 am EDT 		5-day change 1st Jan Change
6.6 SEK -0.75% Intraday chart for Lipum AB +12.82% +1.23%
Apr. 02 Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer CI
Mar. 20 Flerie Invest AB cancelled the acquisition of remaining 67.99% stake in Lipum AB (OM:LIPUM). CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioStock: Lipum's CEO looks ahead after the rights issue
AQ
Lipum announces final outcome of the rights issue
AQ
Lipum - Financed and ready to go
AQ
Lipum announces preliminary outcome of the rights issue
AQ
Lipum and NorthX Biologics enter into new strategic manufacturing alliance
AQ
Lipum has been granted funding from Swelife
AQ
Lipum publishes supplement to the prospectus regarding the rights issue
AQ
Lipum publishes prospectus regarding the rights issue
AQ
BioStock: Lipum seeks patent protecting inflammation-driven cancer treatment
AQ
Lipum AB - Report from the Extraordinary General Meeting
AQ
Lipum strengthens its protection of the drug candidate SOL-116 through a patent application for inflammation-driven cancer
AQ
Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer
CI
BioStock: Lipum has included first RA patient
AQ
Statement from the Board of Directors of Lipum regarding the mandatory public offer from Flerie Invest AB
AQ
Flerie Invest AB cancelled the acquisition of remaining 67.99% stake in Lipum AB (OM:LIPUM).
CI
Lipum Recommends Shareholders to Not Accept Mandatory Cash Offer
CI
LIPUM REPORTS FIRST PATIENT INCLUDED IN THE ONGOING PHASE I CLINICAL STUDY WITH SOL-116
AQ
Lipum AB Reports First Patient Included in the Ongoing Phase I Clinical Study with SOL-116
CI
BioStock: Lipum advances to phase II with capital raise, moves production to Sweden
AQ
Lipum AB (publ) comment on mandatory bid from Flerie Invest AB
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LIPUM Stock
  4. News Lipum AB